{
  "docId": "019de075-7c2e-7510-9012-23bac78506e5",
  "docSlug": "6afb08ad9ecba2144545352067526476",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 20,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The table uses a direct feature-by-feature comparison to establish competitive differentiation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7c2e-7510-9012-23bac78506e5/14",
  "deckHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5",
  "deckJsonHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5.json",
  "deckAnchorHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.13,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "The Symphony™ System and Symphony™ Cartridge have not been cleared or approved by the U.S. FDA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "938e7125-250f-486f-a921-a96bbf523af8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.13,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Source: 1. Bluejay Diagnostics market research. 2. NPV = Negative Predictive Value. 3. Bluejay/Industry information, pending the location of the testing lab. 4. from FDA Emergency Use Authorization company filings",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac301fa4-d50d-4ea5-8c94-e95cbcb5f28b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.68,
        "w": 0.92,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "table",
      "text": "Comparison table of Bluejay Symphony vs Central Lab systems across 8 metrics.",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f5df55d-1028-4b40-8bdb-6f873bcf535c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Symphony™ System Commercial Advantages¹ v. Central Lab Analyzer Systems for IL-6",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7f05d57-1483-4ce1-a3be-139e02dc795a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "e6fd68b7-b65e-4c12-8386-a426070aa93e",
      "evidence": "table/comparison: Comparison table of Bluejay Symphony vs Central Lab systems across 8 metrics.",
      "confidence": 0.5
    },
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "4aaf115c-cafd-4f2b-bee7-011ca814fc0a",
      "evidence": "Comparison table of Bluejay Symphony vs Central Lab systems across 8 metrics.",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "756c8f98-72a4-46be-a4a5-8a105cefc15f",
      "evidence": "Direct side-by-side comparison of product features against competitors.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c2e62651-f3f1-4333-88f5-3a258ba00fce",
      "evidence": "The deck implicitly discusses the cost of inaction by emphasizing the life-threatening nature of sepsis and the benefits of rapid diagnosis.",
      "position": 0,
      "objective": "Highlight the cost of not acting quickly in sepsis diagnosis and treatment.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}